• Policy
• Series of expectorant Prospan generics enter KOR mkt
• by Lee, Tak-Sun Dec 22, 2023 05:46am

• Policy
• Delayed re-evaluation of hyaluronic acid eye drops
• by Lee, Tak-Sun Dec 21, 2023 05:54am

• Policy
• Braftovi Cap. & Bosulif tablets reimb for the New Year
• by Lee, Tak-Sun Dec 21, 2023 05:39am

• Policy
• Bill pending on substituting dispositions for illegal rebate
• by Lee, Jeong-Hwan Dec 20, 2023 05:40am

• Policy
• Forxiga generics continue being released in the Korean mkt
• by Lee, Tak-Sun Dec 20, 2023 05:40am

• Policy
• New drugs Zeposia, Koselugo, Trimbow are reimbursed
• by Lee, Tak-Sun Dec 19, 2023 05:53am

• Policy
• PVA price cut rate will be raised by up to 15%
• by Lee, Tak-Sun Dec 18, 2023 05:31am

• Policy
• Global orphan drug Lamzede receives GIFT designation
• by Lee, Hye-Kyung Dec 15, 2023 05:51am

• Policy
• HER2-positive metastatic breast cancer drug Tukysa approved
• by Lee, Hye-Kyung Dec 15, 2023 05:51am

• Policy
• Non-inferior drugs likely to receive preferential pricing
• by Lee, Tak-Sun Dec 15, 2023 05:51am